61. Specialty Laboratories ::: We Help Doctors Help Patients campylobacter pylori, NSAIDS, and smoking risk factors for peptic ulcer disease. The role of serology in the diagnosis of campylobacter pylori infection. http://www.specialtylabs.com/books/display.asp?id=360

62. The Mayne Florey Medal Winner 1998 SJ, Phillips M, Waters TE, Sanderson CR (1988) A prospective doubleblind trial of duodenal ulcer relapse after eradication of campylobacter pylori, Lancet 2 http://www.tallpoppies.net.au/floreymedal/winner1998.htm

Mayne Florey Medal 1998 Award For the discovery of the Helicobacter Pylori the causative agent in Gastritis and Gastric Ulceration The winners of the inaugural Florey Medal, awarded in 1998, were Dr Robin Warren of the Department of Pathology, Royal Perth Hospital, Western Australia, and Professor Barry Marshall of the Department of Medicine, University of Western Australia. The nominated achievement for which these scientists won the Medal was their identification of a new bacterium, Helicobacter pylori , and their discovery that this bacterium was the cause of both gastritis (inflammation of the stomach) and of gastric ulcer. These discoveries have had a profound effect on both the management of gastroduodenal disease, and the clinical practice of gastroenterology. What Warren and Marshall did, in chronological order,was to: notice that inflammation of the stomach (gastritis) was associated with the presence of a bacterium (Warren); study 100 patients, and discover that this bacterium was present in every patient who suffered from a duodenal ulcer (Warren and Marshall);

63. Campylobacter Links- FoodHACCP.com Briefings Campylobacter Chronic Fowl Hazards Estimated Food Poisoning from Campylobacter and CSPI Gastroenterology campylobacter pylori Genomic tRNA http://www.foodhaccp.com/campylobacter.html

Campylobacter AID - Immunoblots Campylobacter jejuni Campy.jejun ... Campylobacter jejuni tmRNA: CAMPYLOBACTER Campylobacter Campylobacter Campylobacter - Arizona.edu Campylobacter enteritis in humans Campylobacter enteritis- Overview Campylobacter FAQ page Campylobacter in the news ... Campylobacter info ... Campylobacter Infections. WHAT IS CAMPYLOBACTER Campylobacter jejuni Campylobacter jejuni Campylobacter jejuni (Family Practice Notebook.com) Campylobacter jejuni Campylobacter jejuni genome website Campylobacter jejuni -NCSU.edu Campylobacter jejuni organism Campylobacter Questions and Answers Campylobacter UK 2000 meeting Campylobacter Washington University CAMPYLOBACTER ... Back to disease index CAMPYLOBACTER Overseas information: Campylobacter: Low-Profile Bug Is Food Poisoning Leader Campylobacter: No longer the 'quiet' pathogen Campylobacteriosis CAMPYLOBACTERIOSIS (Campylobacter) ... DBMD - Campylobacter Infections - General Information -CDC Information Developments in the Campylobacter Program - FSIS Information DIARRHEA ... CAMPYLOBACTER ENTERITIS Quick Facts available Differentiation of Campylobacter coli and C. jejuni by length

64. Cancer Spectrum CANCERLIT® Citation Go To Home . CANCERLIT® Citation. campylobacter pylori antibodies in humans. Author GI PerezPerez, BM Dworkin, JE Chodos, and MJ Blaser, http://jncicancerspectrum.oupjournals.org/cgi/cancerlit/3288028

Content Sources... JNCI: Current Issue Past Issues Monographs Collections Online Perspectives Journals Cancer News Databases: PDQ PDR Cancer Drugs Cochrane Reviews IARC Monographs Statistics: SEER IARC Incidence WHO Mortality Calendar Useful Links Cancer Dictionary Sign In to JNCI Cancer Spectrum Quick Search Select area All JNCI Journals Cancer Statistics PDQ Cochrane Reviews IARC Monographs PDR Calendar Useful Links Other Search Options Current Issue Past Issues Monographs ... Submission Information Free Sample Issue Table of Contents Alerting Editorial Board About JNCI Search JNCI Other Journals ... Search Cancer Statistics Subscriptions Advertising About JNCI Cancer Spectrum Contact Us Go To: Home Campylobacter pylori antibodies in humans. Author: GI Perez-Perez, BM Dworkin, JE Chodos, and MJ Blaser Source: Ann Intern Med 1988;109(1): 11-7 UI:88239257 Abstract: Mesh Terms: Adolescent Adult Antibodies, Bacterial Antibody Specificity Campylobacter Campylobacter Infections Child Child, Preschool

65. Labogids - CAMPYLOBACTER PYLORI campylobacter pylori. Zie HELICOBACTER PYLORI http://www.az.vub.ac.be/AZlabogids/C/CAMPY100.htm

CAMPYLOBACTER PYLORI Zie: HELICOBACTER PYLORI terug naar Labogids index. AZVUB Labogids

66. H. Pylori RAPID TEST The test is to be used as an aid in the diagnosis of infection due to H. pylori, formely known as campylobacter pylori. Summary and Explanation. http://www.diagnostics.be/Products/Clinical/Quick Test/Latex/333.htm

Ref 333 H. Pylori (20t)Test Kit H. pylori A Rapid Two Step Test for the Detection of Antibodies to H. pylori in Human Serum, Plasma or Whole Blood Intended Use The Cypress Diagnostics H. pylori test is a single use immunochromatographic screening test for the detection of antibodies to Helicobacter pylori in human serum, plasma or blood. The test is to be used as an aid in the diagnosis of infection due to H. pylori, formely known as Campylobacter pylori. Summary and Explanation H. pylori is a spiral, flagellated gram negative bacteria. It colonizes the gastric epithelium of humans and plays a causative role in a variety of gastrointestinal disorders including non-ulcer dyspepsia, duodenal and gastric ulcers, active and chronic gastritis and perhaps the gastric cancer [1-10]. The WHO has designated it as a Class I carcinogen [5]. In patients with signs and symptoms of gastritis, duodenal ulcer or non-ulcer dyspepsia the prevalence rates for H. Pylori infection can exceed 90 percent. Among subjects with a parental history of stomach cancer a much higher prevalence of H. pylori

67. Curriculum Vitae - Stephen P. Holland, M.D. Antibody response to campylobacter pylori in peptic ulcer disease. Immunobiology of campylobacter pylori Antigenic variation among isolates. http://homepage.mac.com/sholland/hollandcv.html

Curriculum Vitae - Stephen P. Holland, M.D. Home Address: Stephen Holland, MD, FACP 3116 Bennett Drive Naperville, IL 60564 630-922-7086 (h) 630-986-7247 (c) eMail: sholland@napervillegi.com Work Address: Stephen Holland, MD, FACP Naperville Gastroenterology 1828 Bay Scott Circle, Suite 112 Naperville, IL 60540 630-357-4463 (effective 1/1/03) eMail: sholland@napervillegi.com Birth date: 1-8-58, Chicago, Illinois Education: Undergraduate: Northwestern University BS 9/1976-6/1980 Honors Program in Medical Education Medical School: Northwestern University MD 9/1978-6/1982 Residency: Loyola University, Internal Medicine, 7/1982-6/1985 Fellowship: NRSA Immunology trainee,University of Alabama, 7/1985-6/1988, with Dr. Jerry McGhee. Fellowship: Gastroenterology, University of Alabama, 7/1988-6/1991 Licensure and Certification: Licensed Physician and Surgeon, Illinois 036-068571 Board Certified Internal Medicine #102384 9/11/85 Board Certified Gastroenterology #102384 11/5/91 Honors and Awards: Winner, Radiology Case of the Week, Department of Radiology

68. Histologic Techniques A rapid stain for campylobacter pylori in gastrointestinal sections using DiffQuik. Development of staining controls for campylobacter pylori. http://members.aol.com/RSRICHMOND/histology.html

Selected Histologic Techniques Diff-Quik II Stain for Helicobacter pylori PRINCIPLE: Helicobacter (formerly Campylobacter) pylori is a large curved gram negative bacillus that often colonizes the mucosal surface of the stomach. The Diff-Quik II stain, similar in action to the Giemsa stain, stains the bacillus fairly sensitively, though not at all specifically. SPECIMEN: The usual specimen is a gastric or duodenal biopsy specimen, fixed in 10% formalin or neutral buffered formalin, paraffin processed, and cut in the usual fashion. Diff-Quik II can also be used as a general bacterial stain for other tissues. PROCEDURE: 1. Deparaffinize sections and hydrate to water. 2. Stain 2 to 3 minutes in Diff-Quik II stain in a Coplin jar. 3. Rinse rapidly in water. 4. Dehydrate rapidly in 100% alcohol and pass to xylene or xylene substitute. 5. Mount in resin. CONTROL: Run a control with every stain run. The control may be a gastric biopsy specimen known to be positive, or a specially prepared control (see reference below). RESULT: Bacteria and fungi are stained dark blue, with very distinct morphologic features. Cell nuclei and other histological structures are also distinctly blue. Helicobacter pylori is seen as large curved, helical, or gull-wing shaped bacilli. Gastrospirillum hominis is clearly stained and easily identified, in the author's experience of a single case.

69. The Scientist - Microbiology By None. CS Goodwin, JA Armstrong, T. Chilvers, M. Peters, et al., Transfer of campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. http://www.the-scientist.com/yr1990/dec/hot5_901210.html

The Scientist 4[24]:0, Dec. 10, 1990 Hot Papers Microbiology By None C.S. Goodwin, J.A. Armstrong, T. Chilvers, M. Peters, et al., "Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively," International Journal of Systematic Bacteriology, 39, 397-405, October 1989. The Scientist 4[24]:0, Dec. 10, 1990 The Scientist We welcome your opinion. If you would like to comment on this article, please write us at editorial@the-scientist.com News Research Hot Papers ... Advertiser Information

70. Campylobacter Sebald And Véron 1963, Genus Basonym ¤ campylobacter pylori subsp. mustelae Fox et al. 1988. Note The name campylobacter pylori subsp. mustelae Fox et al. http://www.bacterio.cict.fr/c/campylobacter.html

Campylobacter Home Genera and taxa above the rank of genus up to and including class: A - C D - L M - R S - Z ... Search Other files: see Home Warning: In the List of Bacterial Names with Standing in Nomenclature Introduction Campylobacter genus . (Type genus of the family Campylobacteraceae Vandamme and De Ley 1991). — Type species: Campylobacter fetus References: SKERMAN (V.B.D.), McGOWAN (V.) and SNEATH (P.H.A.) (editors): Approved Lists of Bacterial Names. Int J Syst Bacteriol Annales de l'Institut Pasteur (Paris) Campylobacter et al Type species: Campylobacter fetus Reference: TANNER (A.C.R.), BADGER (S.), LAI (C.H.), LISTGARTEN (M.A.), VISCONTI (R.A.) and SOCRANSKY (S.S.): Wolinella gen. nov., Wolinella succinogenes Vibrio succinogenes Wolin et al .) comb. nov., and description of Bacteroides gracilis sp. nov., Wolinella recta sp. nov., Campylobacter concisus sp. nov., and Eikenella corrodens from humans with periodontal disease. Int J Syst Bacteriol Campylobacter et al Type species: Campylobacter fetus Reference: VANDAMME (P.), FALSEN (E.), ROSSAU (R.), HOSTE (B.), SEGERS (P.), TYTGAT (R.) and DE LEY (J.): Revision of Campylobacter Helicobacter , and Wolinella taxonomy: emendation of generic descriptions and proposal of Arcobacter gen. nov.

71. H.pylori INTRODUCTION Helicobacter pylori (formerly campylobacter pylori) is a Gramnegative spiral bacterium first successfully cultured from gastric biopsy in 1982. http://www.inet.bg/~usmeds/tests/h.pylori1.html

R apid H .pylori T est Click on the image for a bigger view A Colloidal-gold Based Immunoassay for Use in the Qualitative Detection of Circulating IgG Antibody of Helicobacter Pylori to Human Serum INTRODUCTION Helicobacter pylori (formerly Campylobacter pylori) is a Gram-negative spiral bacterium first successfully cultured from gastric biopsy in 1982. Infection with H.pylori, as demonstrated by evaluation of gastric biopsy or by serology has been associated with Type B gastritis, gastric and duodenal ulcers, and stomach cancer. Coincidence rates of H.pylori infection and some gastroduodenal diseases are from 95 to 98% of individuals with duodenal ulcer, 60-90% of individuals with gastric ulcer, greater than 90% of individuals with type B gastritis, and a majority of individuals with certain forms of stomach cancer. Serological evaluation of patients has been found to be an effective method to determine the presence of H.pylori in the gastric mucosa. In individuals with nonmalignant gastrointestinal disease, eradication of infection with H.pylori is correlated with a rapid resolution of symptoms and cure of disease. PRINCIPLE OF THE TEST PERFORMANCE CHARACTERISTICS The US Meds Rapid H.pylori Test was compared to results obtained in a clinical setting by the histological staining combined with serological evaluation to resolve discrepant results using an EIA specific for IgG reactive to H.pylori and diagnosis of H.pylori-associated disease. The following results were obtained:

72. Campylobacter Pylori In Gastritis & Peptic Ulcer Disease campylobacter pylori in Gastritis Peptic Ulcer Disease Search for books at facultyofchemistry.com. campylobacter pylori in Gastritis http://facultyofchemistry.com/0896401626.html

STUDENT BOOKS ONLINE Faculty Of Chemistry Student Books Online Back To Chemistry Search Featured Universities ... Robert Boyle Looking for more books? Richard Baiocco Melvin D. Joesten Tethers in Space: Proceedings Chemistry Study ... Gender Dysphoria: Interdisciplinary Aproaches in Clinical Management Links For Students Lesson Tutor Shopping Links Shopping Directory Digital Cameras Big Shoes Consumer Electronics ... Martin J. Blaser Published by Igaku-Shoin Medical Pub (August 1989) ISBN 0896401626 Price $69.50 And in the following Categories: Helicobacter pylori infections Medical Medical / Nursing Peptic ulcer ... Microbiology Interested in further search? Try to look for at FetchBook.Info, at CampusI or at Amazon.Com Featured Faculties Mathematics Law Cinema Christianity ... Would you like to exchange links with us ?

73. Warrior Books, Inc: Campylobacter Pylori In Gastritis And Peptic Ulcer Disease B NY IgakuShoin, 1989. 1st Edition....... Author Blaser, Martin J. Title campylobacter pylori in Gastritis and Peptic Ulcer Disease http://www.warriorbooks.com/cgi-bin/war455/019486.html

Login: Password: Quick Search Home Search About Us Contact Us ... Site Map Warrior Books, Inc 1725 Krieger Drive Malabar, FL 32950, USA Fax:(321) 728-0804 Author: Blaser, Martin J. Title: Campylobacter pylori in Gastritis and Peptic Ulcer Disease Description: NY: Igaku-Shoin, 1989. 1st Edition. S. fine/no dj; glossy cover. Item # Order Now more books by by Blaser, Martin J. ... All books are in very good to fine condition unless otherwise noted. We prefer to ship by UPS, but will accommodate customers who prefer Book Rate (media mail). We also offer UPS express services, priority mail, and federal express. Orders are mailed out on the day of receipt or the next day; we do not ship on weekends. Shipping Costs: Our standard shipping charge for a traceable delivery is $6.50 for the first book and $1.00 for each additional book. Media Mail (not traceable): $4.50 for the first book, $1.00 each additional. For Overseas and Canadian customers we will mail by surface or airmail. Global Priority is also available to participating countries; rates noted are for flat rate envelope only, and available only when the book weighs under 4 pounds and can safely be shipped in the envelope. Please email us for quotes on other methods of shipping. Payment Types: We accept Visa, MasterCard, American Express and Diner's Club as well as personal check or money order (in US dollars, drawn on a US bank). Checks should be mailed to Warrior Books, P.O. Box 500985, Malabar, FL 32950. Library and Institutional purchase orders are accepted. Florida residents must add 6% sales tax to purchases.

74. DISCUSION Translate this page Growth of campylobacter pylori in liquid media. Comparison of selective and nonselective media for recovery of campylobacter pylori from antral biopsies. http://www.encolombia.com/gastro14399-deteccion2.htm

DISCUSION Los resultados obtenidos, demostraron que el Helicobacter crece muy bien en el medio HPM, el cual tiene de particular la presencia de carbón activado. Como se ha informado previamente (9), su importancia puede radicar en su capacidad de absorber o inactivar factores tóxicos que resultan del metabolismo bacteriano. El uso de antibióticos es necesario para impedir la proliferación de contaminantes exógenos y, con más frecuencia, de contaminantes endógenos presentes en las biopsias (9-11), principalmente en los pacientes con cáncer gástrico (12-13). El crecimiento del Helicobacter en medio líquido es difícil, debido en parte a que la bacteria requiere una excelente dispersión de gases a través del medio, de un suplemento nutritivo adecuado y de un inóculo inicial denso (8). FIGURA 1. Detección de anticuerpos anti H.pylori por inmunotransferencia. En todos los pacientes con cáncer gástrico, se encontraron anticuerpos anti-H. pylori, mientras que la bacteria fue detectada sólo en 29,4%. Este resultado indica que aunque la bacteria no sea detectada, existió al menos una infección previa. En varios trabajos se ha demostrado que la bacteria puede desaparecer en los casos de atrofia gástrica o puede ser desplazada por otros microorganismos que colonizan el estómago (19-20). Estos resultados indicarían que el dato serológico global sería de poca utilidad en el estudio de estas patologías gástricas; no obstante, es importante determinar si los perfiles de respuesta obtenidos reflejan formas de interacción cuyo análisis sería de valor tanto para el diagnóstico como para el manejo y el seguimiento.

75. El Visick Inicial De Los Pacientes Estudiados Fue campylobacter pylori, acid and bile.J Clin Pathol 1987; 40 1387-90. http://www.encolombia.com/medicina/gastroenterologia/gastro16101invitado2.htm

Con respecto a la evaluación endoscópica en todos los pacientes a quienes se les había realizado cirugía resectiva, se observó un patrón compatible con gastritis de tipo alcalino acompañado con importante reflujo biliar; esto se encontró en los pacientes infectados o libres de infección y no se modificó con el tratamiento de erradicación. Aquellos pacientes que no se sometieron a cirugía resectiva (vagotomía) mostraron un patrón endoscópico normal o de gastropatía crónica, sin modificarse con la erradicación. El Visick inicial de los pacientes estudiados fue: Visick I, 24 pacientes (54,5%); Visick II, 17 pacientes (38,6%); Visick III, 3 pacientes (6,8%), y ningún paciente con Visick IV. La relación entre el Visick inicial y la infección por H. pylori se muestra en la Tabla 2. Tabla 2. Resultado de la detección de H. pylori por mediode biopsia (Bx) y prueba de ureasa (U). MÉTODO N Bx +U + Bx -U + Bx +U - Bx -U - Los pacientes con H. pylori negativo no registraron cambios en el patrón endoscópico, histológico ni clínico, durante el período de seguimiento. Comentario Actualmente, la cirugía ha sido relegada a la resolución de las complicaciones de la enfermedad ulcerosa gastroduodenal, debido al papel fundamental que juegan los inhibidores de la bomba de protones. Esto ha sido aún más manifiesto al conocerse la relación causal de la enfermedad con la infección por H. pylori, aceptándose que la erradicación del mismo es un pilar fundamental en su tratamiento.

76. August 1996 - SMJ: Efficacy Of Ciprofloxacin In The Eradication... 9. Bayerdorffer E, Ottenjann R The role of antibiotics in campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol 1988; 142(suppl)93100. http://www.sma.org/smj/96aug4.htm

Efficacy of Ciprofloxacin in the Eradication of Helicobacter pylori* David Dresner, MD, Walter Coyle, MD, Richard Nemec, MD, Richard Peterson, MD, Thomas Duntemann, MD, and J. Mark Lawson, MD, Portsmouth, Va ABSTRACT: In small preliminary trials, ciprofloxacin has failed to eradicate Helicobacter pylori . Since fluoroquinolones have a marked reduction in bactericidal activity at acidic pH, we altered the gastric pH using omeprazole and investigated the efficacy of ciprofloxacin in eradicating H pylori . Forty-four consecutive patients infected with H pylori were prospectively studied in a randomized, double-blind, controlled trial comparing ciprofloxacin with a placebo for 2 weeks. Both treatment groups received bismuth and omeprazole. In 36 patients, follow-up endoscopy was done 4 weeks after the cessation of all study drugs. The H pylori infection cleared in 13 of 17 patients (76%) in the ciprofloxacin group versus 5 of 19 (26%) in the placebo group. Concurrent administration of omeprazole with ciprofloxacin resulted in increased bactericidal activity against H pylori . Ciprofloxacin when combined with omeprazole and bismuth is efficacious for eradication of H pylori Helicobacter pylori In vitro, ciprofloxacin has relatively low minimum inhibitory concentrations (MICs) against HP.9-12 In vivo, however, ciprofloxacin has failed to eradicate HP.8-10,13,14 Fluoroquinolones with a piperazine substituent at C-7 (ciprofloxacin) have shown decreased antibacterial activity at reduced pH.11,15 In one small study, ofloxacin was administered with an H2 receptor antagonist and 26 of 32 patients recovered from HP infection.16 The goal of our study was to determine the efficacy of ciprofloxacin given with omeprazole in eradicating HP.

77. !HELICOB campylobacter pylori in artificial contaminated milk. Clin Path 1989; 42 778. http://www.meb.uni-bonn.de/kinder/!HELICOB.html

Abteilung für allgemeine Pädiatrie und Poliklinik (Dir. Prof. Dr. Michael J. Lentze) am Zentrum für Kinderheilkunde der Universität Bonn Adenauerallee 119, D-53113 Bonn, Tel 49-228-2873213, Fax 49-228-2873314 KRANKENHAUS HYGIENE Erstellt von Dr. Arne Simon Hygienedatenblatt am Zentrum für Kinderheilkunde der Universität Bonn, Stand 03/98 erstellt von Dr. B.Utsch (Durchsicht PD Dr. K.M. Keller) Helicobacter pylori [Hp] Gramnegatives, spiralförmiges oder gebogenes Stäbchenbakterium. Ureasebildner. Meldepflicht: Keine. Krankheiten: Rezidivierende, chronische Bauchschmerzen (periumbilical oder epigastrisch), nicht-ulzeröse Dyspepsie, Gastritis, Ulcus duodeni, Ulcus ventrikuli, MALT-Lymphom (Wotherspoon 1993), Magenkarzinom (HP wurde von der WHO als karzinogen klassifiziert) Vorkommen, Infektiöses Material: ca 50% der Weltbevölkerung sind Hp-infiziert bzw. besiedelt (Graham 1991). Neuinfektionsrate pro Jahr zunehmendes Lebenalter ca. 1% (Veldhuyzen 1994). Magen, selten extragastral im Oesophagus, Meckel'schen Divertikel, Duodenum, Rektum. Außerdem: Mundschleimhaut, Zahnbelag, Speichel. Trinkwasser (Karim 1989), Nahrungsmittel (West 1990).

78. London Borough Of Enfield Commercial Standards Service - Food Safety They can live in human and animal intestines and are excreted along with faeces. There are two common species Campylobacter jejuni and campylobacter pylori. http://www.tradingstandards.gov.uk/enfield/campylobacter.htm

Civic Centre Silver Street Enfield EN1 3XY Telephone: 020 8379 1000 Fax: 020 8379 4453 Textphone: 020 8379 4419 Infectious Diseases - Campylobacter What is Campylobacter? Campylobacter is a type of bacteria. Bacteria are living things, which are so small that they cannot be seen with the naked eye. They can live in human and animal intestines and are excreted along with faeces. There are two common species: Campylobacter jejuni and Campylobacter pylori Where is Campylobacter Found? Campylobacter may be found on any raw meat, especially offal, and poultry. It may also be found in raw unpasteurised (green top) milk. Campylobacter may also be found in unchlorinated surface water. Many puppies and kittens have also been found to be infected with the bacteria. What are the Symptoms? Campylobacter predominantly causes diarrhoea, severe abdominal pain, fever and headache. Nausea and vomiting may also occur but are less common. Bloody diarrhoea is a common feature in young children. Symptoms usually start 2-5 days after initial infection and last for up to 10 days, and this is why we ask what was eaten up to three days before a person became ill. How can I prevent Infection?

79. Campylobacter Pylori-associated Gastritis: Attempts To Eradicate The Bacteria By 1988 JulOct;51(4-5)329-37. campylobacter pylori-associated gastritis attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens. http://hairmillion.com/rx-online-info/minocycline-online-rx/minocycline-online-r

Drugs online research references Acta Gastroenterol Belg. 1988 Jul-Oct;51(4-5):329-37. Campylobacter pylori-associated gastritis: attempts to eradicate the bacteria by various antibiotics and anti-ulcer regimens. Glupczynski Y, Burette A, Nyst JF, De Prez C, De Koster E, Deltenre M. Int Arch Allergy Appl Immunol. 1985;76(2):151-5. Effect of 24 antimicrobial drugs on polymorphonuclear leukocyte adherence. Li SY, Seow WK, Thong YH. The effects of 24 antimicrobial agents on the adherence of human neutrophils to nylon fibre microcolumns were studied. Neutrophil adherence was found to be remarkably resistant to antimicrobial agents. No effect was observed with penicillin G, nafcillin, cephalothin, vancomycin, bacitracin, tetracycline, minocycline, doxycycline, chloramphenicol, erythromycin, lincomycin, neomycin, streptomycin, acetylspiramycin, 5-fluorocytosine, sulfisoxazole, tinidazole and primaquine. Only 2 enhanced adherence - oxytetracycline and rifampicin - and only 4 suppressed adherence - colistin, polymyxin B, quinine, chloroquine - and then only at high concentrations. Antimicrob Agents Chemother. 1985 May;27(5):879-81.

80. April 2001 Issue-Orginal Article-IJMM 1 Graham DY. campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96 61525. Yoshimura HH. Epidemiology of campylobacter pylori infection. http://www.ijmm.org/archives/apr_01/orginalarticle_c.htm

Official Publication of Indian Association of Medical Microbiologists Original Articles ANTI - H. PYLORI IGG SEROPREVALENCE RATES IN AYMPTOMATIC CHILDREN AND ADULTS FROM SOUTH INDIA PREVALENCE OF SPECIFIC IGM DUE TO TOXOPLASMA, RUBELLA, CMV AND C.TRACHOMATIS INFECTIONS DURING PREGNANCY IDENTIFICATION OF LEPTOSPIRAL ISOLATES BY BACTERIAL RESTRICTION ENDONUCLEASE ANALYSIS (BRENDA) STUDY OF METHICILLIN RESISTANT S. AUREUS (MRSA) ISOLATES FROM HIGH RISK PATIENTS HAEMAGGLUTINATION, HAEMOLYSIN PRODUCTION AND SERUM RESISTANCE OF PROTEUS AND RELATED SPECIES ISOLATED FROM CLINICAL SOURCES ... COLONIZATION OF PREGNANT WOMEN AND THEIR NEWBORN INFANTS WITH GROUP-B STREPTOCOCCI ANTI - H. PYLORI IGG SEROPREVALENCE RATES IN AYMPTOMATIC CHILDREN AND ADULTS FROM SOUTH INDIA V Kate, *N Ananthakrishnan, C Ratnakar, S Badrinath Refrences 1 Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 2 Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 4     61-80 of 95    Back | 1  | 2  | 3  | 4  | 5  | Next 20